REVIEW
|
doi:10.20944/preprints202308.0441.v1
Subject:
Biology And Life Sciences,
Neuroscience And Neurology
Keywords:
blood-brain barrier; mesenchymal stem cell; neurodegenerative diseases; Alzheimer’s disease; neuroinflammation; Parkinson’s disease; multiple sclerosis; stroke
Online: 7 August 2023 (05:26:58 CEST)
COMMUNICATION
|
doi:10.20944/preprints202111.0549.v1
Subject:
Computer Science And Mathematics,
Applied Mathematics
Keywords:
Principal Component Regression, Partial Least Squares, Orthogonal Partial Least Squares, multivariate regression, hypothesis generation, Parkinson’s disease
Online: 29 November 2021 (15:42:03 CET)
REVIEW
|
doi:10.20944/preprints202109.0376.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Alzheimer’s disease; Parkinson’s disease; Aβ cascade hypothesis; a-synuclein aggregation and spreading; transcriptomics of nervous system
Online: 22 September 2021 (11:33:22 CEST)
REVIEW
|
doi:10.20944/preprints202106.0448.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Parkinson’s disease; abnormal involuntary movements; dopaminergic signaling; basal ganglia; spiny projection neurons; neurotransmission; deep brain stimulation
Online: 16 June 2021 (14:17:30 CEST)
REVIEW
|
doi:10.20944/preprints202007.0334.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
alpha-synuclein; SNCA; PARK2; 22q11.2 deletion syndrome; autism spectrum disorders; neuronal development; Parkinson’s disease; neurodegeneration; synaptic dysfunction
Online: 15 July 2020 (11:36:30 CEST)
ARTICLE
|
doi:10.20944/preprints202404.1628.v1
Subject:
Biology And Life Sciences,
Life Sciences
Keywords:
α-synuclein; β-synuclein; γ-synuclein; intrinsically disordered protein; liquid-liquid phase separation; Parkinson’s disease; protein-protein interactions
Online: 24 April 2024 (15:35:56 CEST)
REVIEW
|
doi:10.20944/preprints202011.0396.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
neurodegenerative disease; Alzheimer’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; Huntington’s disease; multiple sclerosis; tryptophan; kynurenines; biomarkers; personalized medicine
Online: 13 November 2020 (20:57:22 CET)
ARTICLE
|
doi:10.20944/preprints202007.0477.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Autism; Schizophrenia; Mental Depression; Ataxia; Fragile X; Parkinson’s disease; Mitochondria; Genes’ expression; Tissues; neurological disorders; nervous systems disorders
Online: 21 July 2020 (11:07:07 CEST)
ARTICLE
|
doi:10.20944/preprints202101.0149.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Apolipoprotein E (ApoE); microtubule associated protein (MAPT); synuclein alpha (SNCA); eQTL; TOMM40; KANSL1; mitochondria; Parkinson’s Progression Markers Initiative (PPMI)
Online: 8 January 2021 (11:45:19 CET)
REVIEW
|
doi:10.20944/preprints202204.0189.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
astrocytes; reactive astrogliosis; TGF-β; traumatic brain injury; stroke; aging; Alzheimer’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; multiple sclerosis; epilepsy
Online: 20 April 2022 (09:06:47 CEST)
REVIEW
|
doi:10.20944/preprints201802.0077.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
nose to brain delivery; nanoparticles; pharmaceutical nanotechnology; mucoadhesion; mucus penetrating particles; targeting; CNS disorders; neurodegenerative diseases; Alzheimer’s disease; Parkinson’s disease
Online: 9 February 2018 (10:37:33 CET)
ARTICLE
|
doi:10.20944/preprints202406.1966.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Akt; cell death; GAPDH; ischemia-like insult; neuroprotection; Nrf2; phosphorylation; Rasagiline; ROS; PC 12 neuronal model; α-synuclein; Parkinson’s disease; stroke
Online: 1 July 2024 (08:40:53 CEST)
REVIEW
|
doi:10.20944/preprints201710.0006.v1
Subject:
Medicine And Pharmacology,
Dietetics And Nutrition
Keywords:
essential fatty acids; ascorbic acid; glutathione; aging; parkinson’s disease; alzheimer’s disease; senescence; nervous system; growth factors; neuroprotection; docosahexaenoic acid; α-linolenic acid.
Online: 2 October 2017 (08:59:13 CEST)
REVIEW
|
doi:10.20944/preprints202207.0171.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Alzheimer’s; aging; amygdala; brain plasticity; CA1; CA3; chronic stress; cognition; GABA; HIF-1; hippocampus; hypoxia; neurogenesis; Parkinson’s; prefrontal cortex; PSA-NCAM; ROS; spatial learning
Online: 12 July 2022 (04:25:55 CEST)
REVIEW
|
doi:10.20944/preprints202209.0139.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Bacillus Calmette-Guérin (BCG); tuberculosis; Non-tuberculous mycobacteria (NTM); nonspecific effects; Trained Immunity; Type 1 Diabetes; Multiple Sclerosis; Parkinson’s Disease; Alzheimer’s disease; Mycobacterium avium ss. paratuberculosis (MAP); molecular mimicry; Global Burden of Disease
Online: 12 September 2022 (09:36:16 CEST)
ARTICLE
|
doi:10.20944/preprints202208.0176.v1
Subject:
Social Sciences,
Psychology
Keywords:
psychological distress/anxiety/depression; dementia; Alzheimer’s disease; Parkinson’s disease; short form of the Depression Anxiety Stress Scale 21; Depression Anxiety Stress Scale 8-items; factor structure; psychometric properties; structural validity; validation; measurement invariance; old age/elders/elderly; informal; family caregivers; spouse; adult children
Online: 9 August 2022 (08:44:11 CEST)